ÀÌ»ó¿îµ¿Áúȯ¿¡¼­ÀÇ ½Å°æ¾È°úÇÐ
Neuro-Ophthalmology in Movement Disorders

´ëÇѾȽŰæÀÇÇÐȸÁö 2014³â 4±Ç 1È£ p.8 ~ p.12

¹ÚÁ¤È£(Park Jeong-Ho) - ¼øÃµÇâ´ëÇб³ Àǰú´ëÇÐ ºÎõº´¿ø ½Å°æ°ú
¼º±â¹ü(Sung Ki-Bum) - ¼øÃµÇâ´ëÇб³ Àǰú´ëÇÐ ºÎõº´¿ø ½Å°æ°ú

Abstract

Eye movement abnormalities in movement disorders may be undetected or ignored because they are relatively subtle compared to their major motor symptoms-hypokinesia or hyperkinesia. However, various kinds of eye movements can be impaired in extrapyramidal disorders involving basal ganglia, such as Parkinson¡¯s disease. Here, we describe overview of neuro-ophthalmologic findings that can be useful in diagnosis, treatment and determining prognosis in patients with movement disorders.

Ű¿öµå

Movement disorder, Eye movement, Basal ganglia, Parkinson¡¯s disease
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå